AQUA-AID, INC. – Trademark Portfolio

Entity Type: 03

AQUA-AID, INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 19 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include OARS, PBS150, AQUIFER, ACIDIPHY, and AQUA-AID. The owner is based in ROCKY MOUNT, NC.

5484 S. OLD CARRIAGE ROAD

ROCKY MOUNT, NC 27803

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AQUA-AID, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (19 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does AQUA-AID, INC. have?

AQUA-AID, INC. has 19 U.S. trademarks filed with the USPTO. Of these, 12 registered, 1 abandoned, 6 cancelled.

What trademark classes does AQUA-AID, INC. file in?

AQUA-AID, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are AQUA-AID, INC.'s most well-known trademarks?

AQUA-AID, INC.'s registered trademark portfolio includes well-known marks such as OARS, PBS150, AQUIFER, ACIDIPHY, and AQUA-AID. These are among 12 currently registered trademarks in the portfolio.

What is AQUA-AID, INC.'s trademark registration success rate?

AQUA-AID, INC. has a 63% trademark registration rate, with 12 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.